A Fatal Case of Life-Threatening Interstitial Pneumonitis Induced by Everolimus for Metastatic Renal Cell Carcinoma: A Comment about the Increased Risk of Interstitial Lung Disease in Japanese
Open Access
- 31 January 2019
- journal article
- case report
- Published by Hindawi Limited in Case Reports in Urology
- Vol. 2019, 1-4
- https://doi.org/10.1155/2019/2703871
Abstract
We describe an 81-year-old woman with metastatic renal cell carcinoma who did not recover from life-threatening interstitial pneumonitis induced by everolimus therapy. She received everolimus due to disease progression after sunitinib, but 2 months after starting everolimus treatment, she visited the emergency department after developing a sudden fever and dyspnea. Chest CT revealed diffuse ground-glass opacities, thickening of the interlobular septa, and consolidation throughout both lung fields. The diagnosis was surmised to be everolimus-induced interstitial pneumonitis. Everolimus administration was stopped and 3 courses of steroid pulse therapy were administered, along with intensive care, but the patient died due to rapid respiratory failure.Keywords
This publication has 20 references indexed in Scilit:
- Interstitial Lung Disease Associated with Gefitinib in Japanese Patients with EGFR-mutated Non-small-cell Lung Cancer: Combined Analysis of Two Phase III Trials (NEJ 002 and WJTOG 3405)Japanese Journal of Clinical Oncology, 2013
- Postmarketing Surveillance Study of Erlotinib in Japanese Patients With Non–Small-Cell Lung Cancer (NSCLC): An Interim Analysis of 3488 Patients (POLARSTAR)Journal of Thoracic Oncology, 2012
- Drug Induced Interstitial Lung DiseaseThe Open Respiratory Medicine Journal, 2012
- Patterns of Interstitial Lung Disease During Everolimus Treatment in Patients with Metastatic Renal Cell CarcinomaJapanese Journal of Clinical Oncology, 2012
- Phase III Trial of Everolimus in Metastatic Renal Cell Carcinoma: Subgroup Analysis of Japanese Patients from RECORD-1Japanese Journal of Clinical Oncology, 2010
- Serum KL-6 in fibrotic NSIP: Correlations with physiologic and radiologic parametersRespiratory Medicine, 2010
- Emerging ethnic differences in lung cancer therapyBritish Journal of Cancer, 2008
- Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trialThe Lancet, 2008
- Predictive Factors for Interstitial Lung Disease, Antitumor Response, and Survival in Non–Small-Cell Lung Cancer Patients Treated With GefitinibJournal of Clinical Oncology, 2006
- Prognostic value of circulating KL‐6 in idiopathic pulmonary fibrosisRespirology, 2006